Page last updated: 2024-08-21

indazoles and incb-018424

indazoles has been researched along with incb-018424 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chougnet, C; Goldwirt, L; Huynh, HH; Le Maignan, C; Madelaine, I; Mourah, S; Plé, A; Pressiat, C; Sauvageon, H	1

Other Studies

1 other study(ies) available for indazoles and incb-018424

Article	Year
Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry. Therapeutic drug monitoring, 2018, Volume: 40, Issue:3 Topics: Angiogenesis Inhibitors; Anilides; Chromatography, Liquid; Humans; Indazoles; Nitriles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry	2018

Article

Year

Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.

Therapeutic drug monitoring, 2018, Volume: 40, Issue:3

Topics: Angiogenesis Inhibitors; Anilides; Chromatography, Liquid; Humans; Indazoles; Nitriles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry

2018